000			02078 a2200565 4500
005			20250513234533.0
264		0	_c20010426
008			200104s 0 0 eng d
022			_a0006-2952
024	7		_a10.1016/s0006-2952(01)00559-7 _2doi
040			_aNLM _beng _cNLM
100	1		_aNédélec, E
245	0	0	_aStimulation of cyclooxygenase-2-activity by nitric oxide-derived species in rat chondrocyte: lack of contribution to loss of cartilage anabolism. _h[electronic resource]
260			_bBiochemical pharmacology _cApr 2001
300			_a965-78 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aCartilage _xcytology
650	0	4	_aChondrocytes _xdrug effects
650	0	4	_aCyclooxygenase 2
650	0	4	_aCyclooxygenase 2 Inhibitors
650	0	4	_aCyclooxygenase Inhibitors _xpharmacology
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aEnzyme Activation _xdrug effects
650	0	4	_aEnzyme Inhibitors _xpharmacology
650	0	4	_aGene Expression Regulation, Enzymologic _xdrug effects
650	0	4	_aIndomethacin _xpharmacology
650	0	4	_aInterleukin-1 _xmetabolism
650	0	4	_aIsoenzymes _xantagonists & inhibitors
650	0	4	_aMale
650	0	4	_aNitric Oxide Synthase _xantagonists & inhibitors
650	0	4	_aNitric Oxide Synthase Type II
650	0	4	_aNitrites _xmetabolism
650	0	4	_aNitrobenzenes _xpharmacology
650	0	4	_aProstaglandin-Endoperoxide Synthases _xgenetics
650	0	4	_aProteoglycans _xbiosynthesis
650	0	4	_aRats
650	0	4	_aRats, Wistar
650	0	4	_aSulfonamides _xpharmacology
650	0	4	_aThiourea _xpharmacology
650	0	4	_aomega-N-Methylarginine _xpharmacology
700	1		_aAbid, A
700	1		_aCipolletta, C
700	1		_aPresle, N
700	1		_aTerlain, B
700	1		_aNetter, P
700	1		_aJouzeau, J
773	0		_tBiochemical pharmacology _gvol. 61 _gno. 8 _gp. 965-78
856	4	0	_uhttps://doi.org/10.1016/s0006-2952(01)00559-7 _zAvailable from publisher's website
999			_c11222339 _d11222339